Welcomes you to the '13th World Biomarkers Congress ' to be held on November 29-30, 2018 at Dublin,Ireland. World Biomarkers 2018 will be organized around the theme: “Advances in Biomarker Research”’
World biomarkers, in the hands of clinical investigators, provide a dynamic and powerful approach to understanding the spectrum of diseases with obvious applications in analytic epidemiology, biomarkers and clinical research in disease prevention, diagnosis, and disease management.
World biomarkers have the additional potential to identify individuals susceptible to disease. There is a good scope to know more in this molecular biomarkers meeting. In the recent years, the information about cancer biomarkers has increased largely providing great scope for improving the management of cancer patients by improving the accuracy of detection and efficacy of treatment.
Latest technological advancement has enabled the examination of many possible biomarkers and renewed interest in developing new biomarkers. All such developments can be evidenced in this world biomarker conference.
A comprehensive discussion of the significance of each biomarker like pharmacodynamics and toxic dynamics of protein biomarkers, analytical biomarkers, and epigenetic biomarkers is going to be held in this biomarkers congress. This conference also includes symposiums and workshop events.
Why to attend World Biomarker 2018?
With members from around the world focused on learning about molecular and cancer biomarkers, and its advances; this is your best opportunity to reach the largest assemblage of participants from the biomarker community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in molecular and cancer biomarkers are hallmarks of this conference.
- Cancer Biomarkers
- Clinical Biomarkers
- Biomarkers and Cancers
- Biomarkers and Non-Cancerous Diseases
- Biomarkers and Radiology
- Cell Free Biomarkers
- Predictive Cancer Biomarkers
- Biomarkers Detection & Discovery
- Biomarkers & Immune-Oncology
- Biomarkers: Validation and Verification
- Advances of Biomarker Testing
- Biomarkers and Personalized Medicine
- Companion Diagnostics
- Biomarkers and Pharmacology
- Cancer Bioinformatics & Biomarkers
- Biomarkers Imaging and Dynamics
- Entrepreneurs Investment Meet